# Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin

> **NCT03804983** · NA · COMPLETED · sponsor: **University of Virginia** · enrollment: 22 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Hybrid Closed Loop (HCL)
- **DEVICE:** Control-IQ with MyTDI

## Key facts

- **NCT ID:** NCT03804983
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2019-02-16
- **Final completion:** 2019-02-16
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804983, "Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03804983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*